• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬前列腺腺癌:分泌性抗原的免疫组织化学检查

Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens.

作者信息

McEntee M, Isaacs W, Smith C

机构信息

Department of Pathology, College of Veterinary Medicine, Cornell University.

出版信息

Prostate. 1987;11(2):163-70. doi: 10.1002/pros.2990110207.

DOI:10.1002/pros.2990110207
PMID:2444955
Abstract

Thirty-one canine adenocarcinomas of prostatic origin were examined immunohistochemically with antibodies generated against three prostate-specific antigens by using a peroxidase-antiperoxidase technique. Primary antibodies included two generated with human prostatic antigens (PSA, PSAP) and one generated with a canine prostatic antigen (CPSP). Eight of 31 adenocarcinomas were positive with CPSP, two were positive with PSA, and three were PSAP positive. Normal and hyperplastic canine prostatic epithelium was strongly positive with all three markers. These results contrast with those in human studies in which PSA and PSAP stain normal and neoplastic epithelium with comparable intensity in all but the most anaplastic tumors.

摘要

采用过氧化物酶-抗过氧化物酶技术,用针对三种前列腺特异性抗原产生的抗体对31例前列腺源性犬腺癌进行免疫组织化学检查。一抗包括两种用人前列腺抗原产生的抗体(PSA、PSAP)和一种用犬前列腺抗原产生的抗体(CPSP)。31例腺癌中有8例CPSP呈阳性,2例PSA呈阳性,3例PSAP呈阳性。正常和增生的犬前列腺上皮对所有三种标志物均呈强阳性。这些结果与人类研究结果形成对比,在人类研究中,除了最间变的肿瘤外,PSA和PSAP对正常和肿瘤上皮的染色强度相当。

相似文献

1
Adenocarcinoma of the canine prostate: immunohistochemical examination for secretory antigens.犬前列腺腺癌:分泌性抗原的免疫组织化学检查
Prostate. 1987;11(2):163-70. doi: 10.1002/pros.2990110207.
2
Prostatic specific antigen: immunoreactivity in urachal remnants.前列腺特异性抗原:脐尿管残余组织中的免疫反应性。
J Urol. 1989 Jun;141(6):1480-2. doi: 10.1016/s0022-5347(17)41351-6.
3
Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.对人前列腺癌进行癌胚抗原、非特异性交叉反应抗原、β-绒毛膜促性腺激素和前列腺特异性抗原的免疫细胞化学评估。
Cancer Res. 1984 Jan;44(1):285-92.
4
Multiple immunoperoxidase markers in benign hyperplasia and adenocarcinoma of the prostate.前列腺良性增生和腺癌中的多种免疫过氧化物酶标志物
Am J Clin Pathol. 1984 Mar;81(3):279-84. doi: 10.1093/ajcp/81.3.279.
5
Variation of prostate-specific antigen expression in different tumour growth patterns present in prostatectomy specimens.前列腺切除标本中不同肿瘤生长模式下前列腺特异性抗原表达的变化。
Urol Res. 1990;18(3):181-7. doi: 10.1007/BF00295844.
6
The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.前列腺酸性磷酸酶和前列腺特异性抗原与前列腺腺癌肿瘤分级的关系:一项免疫组织化学研究。
Prog Clin Biol Res. 1990;357:129-34.
7
A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines.雄激素非依赖型人及大鼠前列腺癌细胞系中前列腺抑制素肽、前列腺酸性磷酸酶和前列腺特异性抗原表达的比较研究
Cancer Lett. 1993 Jul 16;70(3):159-66. doi: 10.1016/0304-3835(93)90226-y.
8
Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.前列腺抗原在膀胱腺癌和绒毛状腺瘤中的免疫组化表达。
Am J Surg Pathol. 2008 Sep;32(9):1322-6. doi: 10.1097/PAS.0b013e3181656ca0.
9
Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands.
Prostate. 1988;12(1):39-46. doi: 10.1002/pros.2990120106.
10
Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques.前列腺标志物的临床应用。I. 利用免疫组织化学技术对前列腺肿瘤进行分类。
Scand J Urol Nephrol Suppl. 1988;107:65-70.

引用本文的文献

1
Anti-tumour effects of lapatinib on HER2-positive canine prostatic carcinoma cell lines.拉帕替尼对 HER2 阳性犬前列腺癌细胞系的抗肿瘤作用。
Open Vet J. 2024 May;14(5):1259-1268. doi: 10.5455/OVJ.2024.v14.i5.21. Epub 2024 May 31.
2
Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in prostatic disorders in dogs.犬前列腺疾病中组织 S100/钙粒蛋白表达与血液中性粒细胞与淋巴细胞比值(NLR)的相关性研究。
BMC Vet Res. 2023 Nov 9;19(1):234. doi: 10.1186/s12917-023-03792-0.
3
Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants.
犬前列腺癌与人前列腺癌变体之间的分子异同
Biomedicines. 2023 Apr 5;11(4):1100. doi: 10.3390/biomedicines11041100.
4
Proteomics Evaluation of Semen of Clinically Healthy Beagle-Breed Dogs.临床健康比格犬精液的蛋白质组学评估
Vet Sci. 2022 Dec 15;9(12):697. doi: 10.3390/vetsci9120697.
5
Advances and challenges of CAR T therapy and suitability of animal models (Review).嵌合抗原受体T细胞疗法的进展与挑战及动物模型的适用性(综述)
Mol Clin Oncol. 2022 Jul 12;17(3):134. doi: 10.3892/mco.2022.2567. eCollection 2022 Sep.
6
Highlights on the Canine Prostatic Specific Esterase (CPSE): A diagnostic and screening tool in veterinary andrology.犬前列腺特异性酯酶(CPSE)概述:兽医男科诊断和筛选工具。
Vet Med Sci. 2021 Jan;7(1):35-40. doi: 10.1002/vms3.349. Epub 2020 Sep 2.
7
Changes in specific serum biomarkers during the induction of prostatic hyperplasia in dogs.犬前列腺增生诱导过程中特定血清生物标志物的变化。
BMC Vet Res. 2019 Dec 5;15(1):440. doi: 10.1186/s12917-019-2201-5.
8
Canine prostate models in preclinical studies of minimally invasive interventions: part I, canine prostate anatomy and prostate cancer models.微创介入临床前研究中的犬前列腺模型:第一部分,犬前列腺解剖结构与前列腺癌模型。
Transl Androl Urol. 2017 Jun;6(3):538-546. doi: 10.21037/tau.2017.03.61.
9
Generation and characterisation of a canine EGFP-HMGA2 prostate cancer in vitro model.犬源EGFP-HMGA2前列腺癌体外模型的构建与表征
PLoS One. 2014 Jun 10;9(6):e98788. doi: 10.1371/journal.pone.0098788. eCollection 2014.
10
PAIII prostate tumors express prostate specific antigen (PSA) in Lobund-Wistar rats.PAIII前列腺肿瘤在Lobund-Wistar大鼠中表达前列腺特异性抗原(PSA)。
Can J Vet Res. 2009 Jan;73(1):39-41.